Tag

FDA

• GRAIL jumps 34% as FDA staff raise no major concerns on Galleri cancer test
  Mara Quinlan · Sep 22, 2026
• FDA psychedelics hearing draws little pushback on future therapeutic use
  Rowan Dunne · Sep 15, 2026
• Replimune tanks on FDA concerns about its skin cancer therapy
  Rowan Dunne · Jul 29, 2026
• Four tech startups turning to Regulation Crowdfunding: A Mugglehead roundup
  Joseph Morton · Jul 24, 2026
• FDA issues recall notice for Tandem Mobi insulin pumps over concerning software glitch
  Rowan Dunne · Apr 27, 2026
• Medtronic spin-out MiniMed lists on Nasdaq, attains EU approval for diabetes tech
  Rowan Dunne · Mar 13, 2026
• Optellum breaks new ground with TGA approval for AI-powered lung nodule solution
  Rowan Dunne · Mar 5, 2026
• Tempus AI builds on FDA win with Median partnership for lung cancer detection
  Rowan Dunne · Feb 24, 2026
• New Jersey hops on the medical psilocybin therapy train
  Rowan Dunne · Jan 22, 2026
• Lung Cancer Research Foundation expands 2025 grant program
  Joseph Morton · Jan 7, 2026
• Maryland task force says natural psychedelics are safe for therapeutic purposes
  Rowan Dunne · Nov 18, 2025
• Researchers to start FDA-approved study on ‘Jedi Mind Fuck’ psilocybin
  Rowan Dunne · Nov 3, 2025
• California governor signs bill to promote state psychedelics research
  Rowan Dunne · Oct 16, 2025
• McMaster surgeon develops AI tool to reduce invasive lung biopsies
  Joseph Morton · Sep 25, 2025
• Inovio advances DNA medicine for debilitating respiratory condition
  Joseph Morton · Aug 29, 2025
• Eight Sleep raises US$100M to propel its AI-integrated mattress technology
  Rowan Dunne · Aug 20, 2025
• AI-integrated toothbrushes are a thing now
  Rowan Dunne · Aug 15, 2025
• Luxury hotel in Singapore starts using 'DeepSleep' sound tech from NuCalm
  Rowan Dunne · Aug 13, 2025
• Whoop on the FDA hot seat for not following marketing rules
  Joseph Morton · Jul 21, 2025
• Johnson & Johnson subsidiary sued for USD$147M for breaching antitrust rules in California
  Joseph Morton · May 21, 2025
• Onc.AI's lung cancer analysis tool gets FDA Breakthrough Device Designation
  Rowan Dunne · Feb 12, 2025
• FDA gives Zai Lab's small cell lung cancer therapeutic orphan drug designation
  Rowan Dunne · Jan 27, 2025
• Sagimet Biosciences up 30% on strong clinical stage data
  Joseph Morton · Dec 16, 2024
• Neurogene patient dies in drug trial, stock surges after FDA says 'use lower dose'
  Rowan Dunne · Nov 23, 2024
• FDA gives long-awaited green light to veterans cannabis trial for PTSD
  Rowan Dunne · Nov 21, 2024
• Breath Diagnostics onboards new president and closes critical financing
  Joseph Morton · Nov 1, 2024
• MIRA Pharma up 27% on ketamine analogue's preclinical results for chemotherapy pain
  Rowan Dunne · Oct 30, 2024
• Novocure scoops FDA approval for electric field lung cancer treatment device
  Rowan Dunne · Oct 16, 2024
• Vivos Therapeutics surges on FDA approval for youth sleep apnea treatment device
  Rowan Dunne · Sep 19, 2024
• Breath Diagnostics takes aim at lung cancer with One Breath
  Joseph Morton · Aug 26, 2024
• Investors wince as FDA panel rejects proposal to approve 'molly' for PTSD therapy
  Rowan Dunne · Jun 6, 2024
• Delta-8 vs Delta-9 THC: What's The Difference?
  Adeline Ee · May 22, 2024
• Inspira Technologies seeks FDA approval for cardiopulmonary device
  Joseph Morton · Dec 20, 2022
• Silo Pharma prepares pre-IND package for FDA on novel ketamine formulation
  Rowan Dunne · Oct 3, 2022
• IceCure Medical aims to bring cold cancer treatment to Vietnam
  Joseph Morton · Aug 31, 2022
• Inspire Medical Systems recruits top tier investor relations talent
  Joseph Morton · Aug 22, 2022
• Phillips Lytle announces the inception of its Psychedelic & Mental Health Therapies Practice
  Rowan Dunne · Aug 19, 2022
• The Mugglehead technology roundup: glowing health edition
  Joseph Morton · Jun 17, 2022
• Tetra Bio-Pharma enters Australia via new subsidiary acquisition
  Rowan Dunne · Jun 6, 2022
• MediPharm Labs to enter US pharmaceutical market via FDA drug registration
  Natalia Buendia Calvillo · Feb 23, 2022
• US CDC and FDA issue warnings on delta-8 THC
  Natalia Buendia Calvillo · Sep 17, 2021
• US Senate bill would finally allow CBD in food and drinks
  Jared Gnam · May 20, 2021
• FDA lifts ban on study of therapists taking MDMA
  Natalia Buendia Calvillo · May 14, 2021
• 67% of PTSD sufferers drop diagnosis in first MDMA Phase 3 trial
  Natalia Buendia Calvillo · May 4, 2021
• US FDA unveils plan to gather 'real-world' data to fill CBD research gaps
  Jared Gnam · Jan 12, 2021
• Dousing strawberries in CBD oil reduces mould, extends shelf life: study
  Jared Gnam · Dec 10, 2020
• FDA issues cannabis research guidelines as CBD industry still hangs in limbo
  Jared Gnam · Jul 25, 2020
• Charlotte's Web backs study on health outcomes of CBD
  Jared Gnam · Jun 10, 2020
• If your company is producing hand sanitizer to fight COVID-19, make sure it’s alcohol-based
  Nick Laba · Apr 9, 2020
• FDA's update on CBD regulations is 'frankly absurd'
  Michelle Gamage · Mar 7, 2020